Safety and efficacy of pegfilgrastim administration on the same day as myelosuppressive chemotherapy (CT) in women with ovarian or primary peritoneal cancer

被引:0
|
作者
Schuman, S. I. [1 ]
Lambrou, N. [1 ]
Robson, K. [1 ]
Gluck, S. [1 ]
Myriounis, N. [1 ]
Pearson, J. [1 ]
Alvarez, E. [1 ]
Crisp, M. P. [1 ]
Twiggs, L. B. [1 ]
Lucci, J. A. [1 ]
机构
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
16009
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Evaluation of the hematologic safety of same day versus standard administration of pegfilgrastim in gynecology oncology patients undergoing platinum-based chemotherapy.
    Billingsley, Caroline C.
    Jacobson, Samuel
    Crafton, Sarah
    Crim, Aleia
    Li, Quan
    Hade, Erinn
    Cohn, David E.
    Fowler, Jeffrey
    Copeland, Larry J.
    Salani, Ritu
    Backes, Floor A. Jennishens
    O'Malley, David M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Safety and efficacy of prophylactic pegfilgrastim on day 3 of neoadjuvant DCF chemotherapy in elderly patients with resectable esophageal cancer.
    Ikeda, Go
    Yoshinami, Yuri
    Kadono, Toru
    Hirose, Toshiharu
    Ohara, Akihiro
    Itoyama, Mai
    Azuma, Ikuko
    Yamamoto, Shun
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Jyunya
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 375 - 375
  • [23] Institutional chart review on same-day pegfilgrastim administration in small cell lung cancer (SCLC) patients receiving myelotoxic chemotherapy
    Choi, Briana
    Alrawashdh, Neda
    Vraney, Jamie
    McBride, Ali
    Abraham, Ivo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [24] Same day administration of pegfilgrastim with dose dense doxorubicin in early breast cancer patients.
    Vance, K. T.
    Carpenter, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 45S - 45S
  • [25] Efficacy and Safety of Balugrastim Compared With Pegfilgrastim in Patients With Breast Cancer Receiving Chemotherapy
    Volovat, Constantin
    Gladkov, Oleg A.
    Bondarenko, Igor M.
    Barash, Steve
    Buchner, Anton
    Bias, Peter
    Adar, Liat
    Avisar, Noa
    [J]. CLINICAL BREAST CANCER, 2014, 14 (02) : 101 - 108
  • [26] Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
    Rossi, Luigi
    Tomao, Federica
    Lo Russo, Giuseppe
    Papa, Anselmo
    Zoratto, Federica
    Marzano, Raffaella
    Basso, Enrico
    Giordani, Erika
    Verrico, Monica
    Ricci, Fabio
    Pasciuti, Giulia
    Francini, Edoardo
    Tomao, Silverio
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 457 - 462
  • [27] A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube or primary peritoneal cancer
    Nanki, Yoshiko
    Nomura, Hiroyuki
    Iwasa, Naomi
    Saotome, Keiko
    Dozen, Ai
    Yoshihama, Tomoko
    Hirano, Takuro
    Hashimoto, Shiho
    Chiyoda, Tatsuyuki
    Yamagami, Wataru
    Kataoka, Fumio
    Aoki, Daisuke
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (01) : 54 - 59
  • [28] Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
    Webber, Kate
    Friedlander, Michael
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 126 - 138
  • [29] Early administration of pegfilgrastim contributes to the safety of DCF therapy as neoadjuvant chemotherapy for esophageal cancer
    Morita, Ryuichi
    Ishikawa, Takeshi
    Endo, Yuki
    Yasuda, Takeshi
    Oka, Kaname
    Sakakida, Tomoki
    Matsumura, Shinya
    Mizushima, Katsura
    Doi, Toshifumi
    Okayama, Tetsuya
    Katada, Kazuhiro
    Kamada, Kazuhiro
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Fujiwara, Hitoshi
    Konishi, Hideyuki
    Itoh, Yoshito
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1422 - S1422
  • [30] Safety of same-day pegfilgrastim administration and incidence of cystitis and ureteritis in mCRPC treated with cabazitaxel ± carboplatin.
    Bilen, Mehmet Asim
    Cauley, Diana H.
    Atkinson, Bradley J.
    Chen, Hsiang-Chun
    Kaya, Diana
    Wang, Xuemei
    Vikram, Raghu
    Tu, Shi-Ming
    Corn, Paul Gettys
    Kim, Jeri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)